...
首页> 外文期刊>Food Chemistry >Biogenic antioxidative and anti-inflammatory aryl polyketides from the venerid bivalve clam Paphia malabarica
【24h】

Biogenic antioxidative and anti-inflammatory aryl polyketides from the venerid bivalve clam Paphia malabarica

机译:黄ven双壳蛤Paphia malabarica的生物抗氧化和消炎性芳基聚酮化合物

获取原文
获取原文并翻译 | 示例
           

摘要

Chemical investigation of ethyl acetate-methanol extract of the venerid bivalve clam Paphia malabarica led to isolation of three unprecedented aryl polyketide derivatives, characterized as (E)-12-(17-ethyl-tet rahydro-16-hydroxy-15-(methyl pentanoate)-14-oxo-2H-pyran-13-yl)-9-methyl-but-11-enyl benzoate (1), isobutyl-13-(6-(benzoyloxy)-10-methylpentyl)-tetrahydro-13-methyl-2H-pyran-17-carboxylate (2) and (13-(methoxycarbonyl)-11-((E)-18-ethylhexa-16,19-dienyl)-12-propyl-cyclohex-10-enyl)-methyl-3-hydroxy benzoate (3). The structures of the polyketides were assigned by extensive spectroscopic experiments. Compound 1 displayed comparatively greater 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical quenching potential (50% inhibitory concentration, IC50 similar to 0.59 mg/mL) than commercially available alpha-tocopherol (IC50 0.63 mg/mL). Potential pro-inflammatory 5-lipoxygenase (5-LOX) inhibition potential (IC50 0.76-0.92 mg/mL) of the polyketides in consonant with significantly greater anti-inflammatory selectivity indices (anti-cyclooxygense-1(IC50)/anti-cyclooxygense-2(IC50) > 1) than non-steroidal anti-inflammatory agent ibuprofen (0.44) described the safety profile of the title compounds. Putative biosynthetic route by means of polyketide synthatase biocatalyzed pathways unambiguously established the structural assignments of the previously undescribed polyketide analogues. The potential of hitherto undescribed polyketides from P. malabarica as natural antioxidative and anti-inflammatory functional food ingredients was demonstrated in the present study. (C) 2017 Elsevier Ltd. All rights reserved.
机译:对青er双壳蛤Paphia malabarica的乙酸乙酯-甲醇提取物的化学研究导致分离出三种前所未有的芳基聚酮化合物衍生物,其特征为(E)-12-(17-乙基-tet rahydro-16-羟基-15-(戊酸甲酯) )-14-氧代-2H-吡喃-13-基)-9-甲基-丁基-1-烯基苯甲酸酯(1),异丁基-13-(6-(苯甲酰氧基)-10-甲基戊基)-四氢-13-甲基-2H-吡喃-17-羧酸盐(2)和(13-(甲氧羰基)-11-((E)-18-乙基六-16,19-二烯基)-12-丙基-环己基-10-烯基)-甲基- 3-羟基苯甲酸酯(3)。通过广泛的光谱实验确定了聚酮化合物的结构。与市售的α-生育酚(IC50为0.63 mg / mL)相比,化合物1显示出相对较高的2,2-二苯基-1-吡啶基肼基(DPPH)自由基猝灭潜能(50%抑制浓度,IC50类似于0.59 mg / mL)。聚酮化合物潜在的促炎性5-脂氧合酶(5-LOX)抑制潜能(IC50 0.76-0.92 mg / mL),同时具有明显更高的抗炎选择性指数(anti-cyclooxygense-1(IC50)/ anti-cyclooxygense- 2(IC50)> 1)比非甾体抗炎药布洛芬(0.44)描述了标题化合物的安全性。通过聚酮化合物合酶的生物催化途径推定的生物合成途径明确地建立了先前未描述的聚酮化合物类似物的结构。在本研究中证明了迄今为止从未描述过的疟原虫中的聚酮化合物作为天然抗氧化和抗炎功能食品成分的潜力。 (C)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号